Table 3.
Smoking status at the time of analyses, Umraniye Training and Research Hospital, Istanbul, Turkey, 2020 (N=579)
| Varenicline | Bupropion | NRT | Psychosocial support | p a | |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | ||
| Long-term successful quit | 37 (15.7) | 14 (15.7) | 19 (17.0) | 4 (2.8) | <0.001 |
| Relapse after initial quit | 70 (29.8) | 20 (22.5) | 18 (16.1) | 2 (1.4) | |
| Quit after a period from initial intervention | 9 (3.8) | 6 (6.7) | 10 (8.9) | 27 (18.9) | |
| Fail to quit | 119 (50.6) | 49 (55.1) | 65 (58.0) | 110 (76.9) |
a
p<0.001 when all intervention groups were compared; p=0.103 when only medications (varenicline, bupropion, NRT) were compared.
NRT: nicotine replacement therapy.